Encorafenib + cetuximab (EC) BREAKWATER Study Reveals Breakthrough in Treating BRAF V600E-Mutant Metastatic Colorectal Cancer Gastrointestinal Cancer Treatment 3 Mins Read The latest findings from the BREAKWATER study, a phase 3 clinical trial, have shown significant strides in improving treatment outcomes…
